In conclusion, we suggest that Axin1/β-catenin/MMP-7 may be a useful prognostic marker for CRC progression and in determining the sensitivity of 5-HT1DR as a potential target for patients with CRC. The gene discussed is MMP7; the disease is colorectal carcinoma.